Open, Multi-center, Non-interventional, Prospective/ Retrospective Observational Study on Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Healthy Volunteers: f
View:
• Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
• Children who has official height record at least 6 months prior
Locations
Other Locations
Republic of Korea
Yonsei University Health System, Severance Hospital
RECRUITING
Seoul
Contact Information
Primary
Sung
jhsung@donga.co.kr
+82-2-920-8369
Time Frame
Start Date: 2021-02-08
Estimated Completion Date: 2035-02
Participants
Target number of participants: 5000
Treatments
Growth hormone
Growtropin®-II
Related Therapeutic Areas
Sponsors
Leads: Dong-A ST Co., Ltd.